Glaxo Wellcome Inc.

• Position: Brief Article - Statistical Data Included

RESEARCH TRIANGLE PARK -- Glaxo Wellcome Inc. has received U.S. Food and Drug Administration approval for Advair Diskus, the only drug that simultaneously treats both of the underlying causes of asthma: inflammation of air passages and constricted...